TABLE 2.
Inheritance of Bphs, Bpss, and Bpbs in F1 hybrid strainsa
Phenotype and strain | Classification | No. of mice with phenotype/total (P value) |
Contrasts | ||
---|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | |||
Bphs | |||||
SJL/J | Bphs+ Bpss+ Bpbs+ | 6/6b | 6/6c | 5/6d | |
C3H/HeJ | Bphs− | 0/6b | 0/6c | 0/6d | |
(C3H × SJL)F1 | 6/6b (0.0001) | 6/6c (0.0001) | 4/6d (0.0094) | SJL/J = (C3H × SJL)F1 > C3H/HeJ | |
C57BL/6J | Bphs+ Bpbs+ | 6/6b | 6/6c | 1/6d | |
CBA/J | Bphs− | 0/6b | 0/6c | 0/6d | |
(B6 × CBA)F1 | 6/6b (0.0001) | 6/6c (0.0001) | 2/6d (0.3) | C57BL/6J = (B6 × CBA)F1 > CBA/J | |
Bpss | |||||
SJL/J | Bphs+ Bpss+ Bpbs+ | 12/12e | 12/12f | 6/11g | |
PL/J (control) | Bpss+ | 6/6e | 0/8f | 0/4g | |
(PL × SJL)F1 | 8/9e (0.35) | 1/9f (<0.0001) | 0/5g (0.03) | SJL/J > PL/J = (PL × SJL)F1 | |
SJL/J | 12/12e | 12/12f | 6/11g | ||
BALB/cJ | Bpss− | 3/10e | 6/17f | 0/5g | |
(BALB × SJL)F1 | 6/9e (0.001) | 4/8f (0.002) | 0/5g (0.02) | SJL/J > BALB/cJ = (BALB × SJL)F1 | |
AKR/J | Bphs+ Bpss+ Bpbs+ | 12/12e | 10/10f | 8/17g | |
DBA/2J | Bpss− | 4/15e | 0/14f | 0/4g | |
(AK × DBA)F1 | 4/8e (0.0003) | 0/8f (<0.0001) | 0/5g (0.05) | AKR/J > DBA/2J = (AK × DBA)F1 | |
SJL | 10/10e | 10/10f | 6/10g | ||
B10.S | Bpss− | 1/10e | 1/10f | 0/10g | |
(B10 × SJL)F1 | 1/10e (<0.0001) | 0/10f (<0.0001) | 0/10g (0.0006) | SJL/J > B10.S = (B10 × SJL)F1 | |
Bpbs | |||||
SJL/J | Bphs+ Bpss+ Bpbs+ | 6/6h | 6/6i | 4/6j | |
B10.S | Bpbs− | 1/6h | 0/6i | 0/6j | |
(B10 × SJL)F1 | 2/6h (0.009) | 1/6i (0.0007) | 0/5j (0.008) | SJL/J > B10.S = (B10 × SJL)F1 |
F1 hybrids were generated by using the indicated parental strains. Mice were then challenged for Bphs, Bpss, or Bpbs at the indicated doses. Significance of difference in susceptibility between parental strains and F1 hybrids was determined using Fisher's exact test.
HA challenge dose, 25 mg/kg free base.
HA challenge dose, 12.5 mg/kg free base.
HA challenge dose, 3.1 mg/kg free base.
5-HT challenge dose, 50 mg/kg free base.
5-HT challenge dose, 12.5 mg/kg free base.
5-HT challenge dose, 3.1 mg/kg free base.
BDK challenge dose, 80 mg/kg peptide.
BDK challenge dose, 40 mg/kg peptide.
BDK challenge dose, 20 mg/kg peptide.